Search

Showing results for: AUTHOR - Tam, CS

Found: 9 results

Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy Blood Adv - 2020-10-13 Davis, JE; Handunnetti, SM; Ludford-Menting, M; Sharpe, C; Blombery, P; Anderson, MA; Roberts, AW; Seymour, JF; Tam, CS; Ritchie, DS; Koldej, RM
Link to Open Access at Publisher's Site Download PDF
Undetectable peripheral blood MRD should be the goal of venetoclax in CLL, but attainment plateaus after 24 months Blood Advances - 2020-01-14 Lew, TE; Anderson, MA; Lin, VS; Handunnetti, SM; Came, NA; Blombery, P; Westerman, DA; Wall, M; Tam, CS; Roberts, AW; Seymour, JF
Link to Open Access at Publisher's Site Download PDF
Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia Cancer Discovery - 2019-03 Blombery, P; Anderson, MA; Gong, JN; Thijssen, R; Birkinshaw, RW; Thompson, ER; Teh, CE; Nguyen, T; Xu, Z; Flensburg, C; Lew, TE; Majewski, IJ; Gray, DHD; Westerman, DA; Tam, CS; Seymour, JF; Czabotar, PE; Huang, DCS; Roberts, AW
Link to Publisher's Version
Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma Nature Medicine - 2018-11-19 Agarwal, R; Chan, YC; Tam, CS; Hunter, T; Vassiliadis, D; Teh, CE; Thijssen, R; Yeh, P; Wong, SQ; Ftouni, S; Lam, EYN; Anderson, MA; Pott, C; Gilan, O; Bell, CC; Knezevic, K; Blombery, P; Rayeroux, K; Zordan, A; Li, J; Huang, DCS; Wall, M; Seymour, JF; Gray, DHD; Roberts, AW; Dawson, MA; Dawson, SJ
Link to Publisher's Version
Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma New England Journal of Medicine - 2018-03-29 Tam, CS; Anderson, MA; Pott, C; Agarwal, R; Handunnetti, S; Hicks, RJ; Burbury, K; Turner, G; Di Iulio, J; Bressel, M; Westerman, D; Lade, S; Dreyling, M; Dawson, SJ; Dawson, MA; Seymour, JF; Roberts, AW
Link to Publisher's Version
Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemia Nat Commun - 2017-03-17 Yeh, P; Hunter, T; Sinha, D; Ftouni, S; Wallach, E; Jiang, D; Chan, YC; Wong, SQ; Silva, MJ; Vedururu, R; Doig, K; Lam, E; Arnau, GM; Semple, T; Wall, M; Zivanovic, A; Agarwal, R; Petrone, P; Jones, K; Westerman, D; Blombery, P; Seymour, JF; Papenfuss, AT; Dawson, MA; Tam, CS; Dawson, SJ
Link to Publisher's Version
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study Lancet Oncol - 2017-02 Seymour, JF; Ma, S; Brander, DM; Choi, MY; Barrientos, J; Davids, MS; Anderson, MA; Beaven, AW; Rosen, ST; Tam, CS; Prine, B; Agarwal, SK; Munasinghe, W; Zhu, M; Lash, LL; Desai, M; Cerri, E; Verdugo, M; Kim, SY; Humerickhouse, RA; Gordon, GB; Kipps, TJ; Roberts, AW
Link to Publisher's Version Link to PubMed Central Version
Treatment of patients with Waldenstrom macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group Intern Med J - 2017-01 Talaulikar, D; Tam, CS; Joshua, D; Ho, JP; Szer, J; Quach, H; Spencer, A; Harrison, S; Mollee, P; Roberts, AW; Horvath, N; Lee, C; Zannettino, A; Brown, R; Augustson, B; Jaksic, W; Gibson, J; Kalff, A; Johnston, A; Trotman, J; Kalro, A; Grigoriadis, G; Ward, C; Prince, HM
Link to Publisher's Version
Progress in BCL2 inhibition for patients with chronic lymphocytic leukemia Semin Oncol - 2016-04 Tam, CS; Seymour, JF; Roberts, AW
Link to Publisher's Version

An error has occurred. This application may no longer respond until reloaded. Reload 🗙